Pacific biosciences of california stock.
PacBio Announces Third Quarter 2023 Financial Results. MENLO PARK, Calif. , Oct. 30, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended September 30, 2023 . Third quarter results Revenue of $55.7 million , a 72% increase compared with $32.3 million in the prior-year period. October 30, 2023.
PDF Version. MENLO PARK, Calif., Jan. 24, 2023 /PRNewswire/ -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) ("PacBio") today announced that it intends to offer and sell $150.0 million of shares of its common stock in an underwritten public offering. PacBio also intends to grant the underwriters a 30-day option to purchase up to an ...Dec 4, 2023 · Ulysses Erickson. December 4, 2023. Company. Pacific Biosciences of California Inc (NASDAQ:PACB) has a beta value of 1.83 and has seen 0.81 million shares traded in the recent trading session. The company, currently valued at $2.37B, closed the recent trade at $8.86 per share which meant it lost -$0.02 on the day or -0.17% during that session. Pacific Biosciences of California Inc’s price is currently up 27.53% so far this month. During the month of March, Pacific Biosciences of California Inc’s stock price has reached a high of $11.79 and a low of $8.01. Over the last year, Pacific Biosciences of California Inc has hit prices as high as $14.20 and as low as $3.85.See Pacific Biosciences of California, Inc. stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy.Pacific Biosciences of California Trading Up 4.7 %. Shares of PACB opened at $8.88 on Friday. The firm’s 50 day simple moving average is $7.76 and its 200 day simple moving average is $10.63.
Pacific Biosciences of California Stock Up 4.7 %. Pacific Biosciences of California stock opened at $8.88 on Friday. The company has a debt-to-equity ratio of 1.17, a quick ratio of 4.43 and a ...Christian O. Henry. Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template ...Pacific Biosciences of California, Inc. (Nasdaq: PACB) ("PacBio") today announced that it has priced its previously announced underwritten public offering of 17,500,000 shares of its common stock ...
٢٠/١١/٢٠٢٣ ... PACB has a roughly average overall score of 41 meaning the stock holds a better value than 41% of stocks at its current price.
Pacific Biosciences Of California. stock was originally listed at a price of $16.44 in Oct 27, 2010. If you had invested in Pacific Biosciences Of California stock at $16.44 , your return over the last 13 years would have been -47.99% , for an annualized return of -4.9% (not including any dividends or dividend reinvestments).Pacific Biosciences of California Inc (NASDAQ:PACB)’s traded shares stood at 3.89 million during the last session, with the company’s beta value hitting 1.76. At the close of trading, the stock’s price was $8.36, to imply an increase of 0.97% or $0.08 in intraday trading.The stock of Pacific Biosciences of California (PACB 2.27%), a company developing DNA sequencing machines, is losing ground after an investor update. Preliminary fourth-quarter sales figures ...Jan 11, 2022 · The stock of Pacific Biosciences of California (PACB 2.27%), a company developing DNA sequencing machines, is losing ground after an investor update. Preliminary fourth-quarter sales figures ... Management will host a quarterly conference call to discuss its first quarter ended March 31, 2022, results today at 5:00 p.m. Eastern Time. Investors may listen to the call by dialing 866-652-5200, or if outside the U.S., by dialing 412-317-6060, and request to join the “PacBio Q1 Earnings Call.”. The call will be webcast live and will be ...
٠٣/٠٤/٢٠٢١ ... Pacbio (Pacific Biosciences of California Inc) (Stock: PACB) CEO Christian Henry Interview on Business Outlook and Growth.
Pacific Biosciences of California, Inc. (NASDAQ: PACB) is a premier life science technology company that is designing, developing and manufacturing advanced sequencing solutions to help scientists ...
Pacific Biosciences of California, Inc. (NASDAQ: PACB) is a California-based biotech firm founded in 2004. It is ranked seventh on our list of 10 best biotech stocks to buy according to Cathie Wood.Of course Pacific Biosciences of California may not be the best stock to buy.So you may wish to see this free collection of growth stocks.. Please note, the market returns quoted in this article ...Pacific Biosciences of California, Inc. (PACB) latest earnings report: revenue, EPS, surprise, history, news and analysis.Pacific Biosciences of California Inc Stock , PACB 8.95 +0.07 +0.79% After-market 07:47:07 PM EDT 12/1/2023 NASDiscover Pacific Biosciences of California's earnings and revenue growth rates, forecasts, and the latest analyst predictions while comparing them to its industry peers. ... Independent Director exercised options and sold US$793k worth of stock May 29. The Pullback In Pacific Biosciences Makes For A Much More Interesting Opportunity …Pacific Biosciences of California (PACB) Q4 2021 Earnings Call Transcript PACB earnings call for the period ending December 31, 2021. Motley Fool Transcribing | Feb 16, 2022
Pacific Biosciences of California Inc’s ( PACB) price is currently up 16.83% so far this month. During the month of November, Pacific Biosciences of California Inc’s stock price has reached a high of $7.45 and a low of $5.74. Over the last year, Pacific Biosciences of California Inc has hit prices as high as $14.55 and as low …Pacific Biosciences of California, Inc. (Nasdaq: PACB) ("PacBio") today announced that it intends to offer and sell $150.0 million of shares of its common stock in an underwritten public offering.Track Pacific Biosciences of California Inc (PACB) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Pacific Biosciences of California, Inc.'s (NASDAQ:PACB) price-to-sales (or "P/S") ratio of 19.7x might make it look like a strong sell right now compared to the Life Sciences industry in the ...Pacific Biosciences of California Non-GAAP EPS of -$0.34 in-line, revenue of $35.5M beats by $0.34M SA News Wed, Aug. 03, 2022 As China looks to open up, here are the stocks with the most revenue ...
Pacific Biosciences of California has a 12-month low of $5.74 and a 12-month high of $14.55. The stock has a market capitalization of $2.26 billion, a PE ratio of -6.65 and a beta of 1.72. The company has a debt-to-equity ratio of 1.17, a current ratio of 4.80 and a quick ratio of 4.43. Pacific Biosciences of California ( NASDAQ:PACB – …Pacific Biosciences of California (NASDAQ:PACB) and Olink Holding AB (publ) are both mid-cap medical companies, but which is the superior business?We will compare the two businesses based on the strength of their profitability, institutional ownership, community ranking, earnings, media sentiment, analyst recommendations, risk, dividends and valuation.
Pacific Biosciences of California Inc’s ( PACB) price is currently down 20.92% so far this month. During the month of February, Pacific Biosciences of California Inc’s stock price has reached a high of $12.35 and a low of $8.71. Over the last year, Pacific Biosciences of California Inc has hit prices as high as $14.20 and as low as …Pacific Biosciences of California, Inc. has a twelve month low of $5.74 and a twelve month high of $14.55. The stock has a market cap of $2.37 billion, a P/E ratio of -6.99 and a beta of 1.78. The ...The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA. Pacific Biosciences of California Inc. 1305 O'Brien Drive. Menlo ...The five states that border the Pacific Ocean are California, Oregon, Washington, Alaska and Hawaii. The proximity of the states to the Pacific Ocean affects their climate. Along the coast, temperatures vary by as much as 19 degrees Fahrenh...Management will host a quarterly conference call to discuss its first quarter ended March 31, 2022, results today at 5:00 p.m. Eastern Time. Investors may listen to the call by dialing 866-652-5200, or if outside the U.S., by dialing 412-317-6060, and request to join the “PacBio Q1 Earnings Call.”. The call will be webcast live and will be ... Pacific Biosciences of California, Inc. beats earnings expectations. Reported EPS is $-0.26, expectations were $-0.3. Operator: Good afternoon, everyone, and welcome to the PacBio Third Quarter ...Pacific Biosciences of California Inc (NASDAQ: PACB) has experienced a rise in its stock price by 4.67 compared to its previous closing price of 8.36. However, the company has seen a gain of 15.28% in its stock price over the last five trading days. Seeking Alpha reported 2023-11-20 that Pacific Biosciences reported a 72% YoY […]Pacific Biosciences of California (NASDAQ:PACB) rose 3.16% Friday pre-market after UBS upgraded the sequencing systems company on a strong "Revio" demand. ... The stock is currently trading at $7. ...The stock of Pacific Biosciences of California (PACB 2.27%), a company developing DNA sequencing machines, is losing ground after an investor update. Preliminary fourth-quarter sales figures ...
UBS Upgrades Pacific Biosciences of California to Buy From Neutral, Cuts Price Target to $10 From $13. Nov. 17. MT. Piper Sandler Trims Price Target on Pacific Biosciences of …
Pacific Biosciences of California, Inc. is a life science technology company. The Company designs, develops and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. ... Stock Pacific Biosciences of California, Inc. - Nasdaq . News Pacific Biosciences of California, Inc ...
Stock Quote. Price Change Change(%) Volume 52 Week High 52 Week Low ... Pacific Biosciences of California, Inc. 1305 O’Brien Drive, Menlo Park, CA 94025 [email protected] the latest Pacific Biosciences of California, Inc. (PACB) stock quote, history, news and other vital information to help you with your stock trading and investing.Pacific Biosciences of California Inc (PACB). Industry Medical Devices. Deal. This stock can be held in an Investment ISA and an Investment Account. Sell. $6.55.Reassessing Pacific Biosciences: Deep Dive Into Q3 2023 Revenue Surge And Market Dynamics 11/20/23-9:07AM EST Seeking Alpha Pacific Biosciences of California rises after UBS upgrades on strong ...As of November 17, 2023, 4:00 PM, CST, Pacific Biosciences of California Inc’s stock price was $8.40. Pacific Biosciences of California Inc is up 10.67% from its previous closing price of $7.59. During the last market session, Pacific Biosciences of California Inc’s stock traded between $7.44 and $7.68.Pacific Biosciences Of California reported $68.26M in Stock for its fiscal quarter ending in September of 2023. Data for Pacific Biosciences Of California ...Get the latest Pacific Biosciences of California Inc. (PACB) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.Pacific Biosciences of California, Inc.'s (NASDAQ:PACB) price-to-sales (or "P/S") ratio of 19.7x might make it look like a strong sell right now compared to the Life Sciences industry in the ...Pacific Biosciences Of California Inc. (NASDAQ: PACB) is a biotechnology company. In the last three months, Pacific Biosciences Of California Inc. (NASDAQ: PACB) stock gained 182% and on February ...
The Pacific Biosciences of California stock price gained 4.72% on the last trading day (Friday, 1st Dec 2023), rising from $8.48 to $8.88. During the last trading day the stock fluctuated 8.77% from a day low at $8.21 to a day high of $8.93. The price has risen in 7 of the last 10 days and is up by 17% over the past 2 weeks.Nov 26, 2023 · Pacific Biosciences of California Stock Up 2.3 %. Shares of NASDAQ:PACB opened at $8.55 on Friday. The company has a debt-to-equity ratio of 1.17, a current ratio of 4.80 and a quick ratio of 4.43. Pacific Biosciences of California Inc is up 8.17% from its previous closing price of $7.22. During the last market session, Pacific Biosciences of California Inc’s stock traded between $7.00 and $7.43. Currently, there are 255.00 million shares of Pacific Biosciences of California Inc stock available for purchase.Instagram:https://instagram. how to get started with forexsibgrare earth etfstocks overvalued Pacific Biosciences of California Trading Up 4.7 %. Shares of PACB opened at $8.88 on Friday. The firm’s 50 day simple moving average is $7.76 and its 200 day simple moving average is $10.63.Pacific Biosciences of California Inc (NASDAQ: PACB) has seen a rise in its stock price by 10.74 in relation to its previous close of 6.52. However, the company has experienced a 1.55% gain in its stock price over the last five trading sessions. Zacks Investment Research reported 2023-10-31 that PacBio (PACB) witnesses strong revenue … jpm large cap growthwebull how to paper trade Pacific Biosciences Of California Inc. (NASDAQ: PACB) is a biotechnology company. In the last three months, Pacific Biosciences Of California Inc. (NASDAQ: PACB) stock gained 182% and on February ...Complete Pacific Biosciences of California Inc. stock information by Barron's. View real-time PACB stock price and news, along with industry-best analysis. stock projections Pacific Biosciences of California Inc (NASDAQ: PACB) has experienced a rise in its stock price by 4.67 compared to its previous closing price of 8.36. However, the company has seen a gain of 15.28% in its stock price over the last five trading days. Seeking Alpha reported 2023-11-20 that Pacific Biosciences reported a 72% YoY […]Published: SATURDAY DECEMBER 2, 2023. Pacific Biosciences of California (PACB) stock hit day 0 of a continuous streak of days with losses, with cumulative ...